Price T Rowe Associates Inc Avidity Biosciences, Inc. Transaction History

Price T Rowe Associates Inc

  • $867 Billion
  • Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 11,042,823 shares of RNA stock, worth $353 Million. This represents 0.04% of its overall portfolio holdings.

Number of Shares
11,042,823
Previous 10,633,962 3.84%
Holding current value
$353 Million
Previous $488 Million 34.25%
% of portfolio
0.04%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$29.08 - $52.5 $11.9 Million - $21.5 Million
408,861 Added 3.84%
11,042,823 $321 Million
Q3 2024

Nov 14, 2024
SELL
$37.21 - $48.14 $10.5 Million - $13.6 Million
-282,664 Reduced 2.59%
10,633,962 $488 Million
Q2 2024

Aug 14, 2024
BUY
$22.73 - $40.85 $79.3 Million - $142 Million
3,487,519 Added 46.94%
10,916,626 $446 Million
Q1 2024

May 15, 2024
BUY
$9.16 - $25.52 $4.73 Million - $13.2 Million
516,446 Added 7.47%
7,429,107 $190 Million
Q4 2023

Feb 14, 2024
BUY
$4.87 - $9.37 $1.44 Million - $2.78 Million
296,238 Added 4.48%
6,912,661 $62.6 Million
Q3 2023

Nov 14, 2023
SELL
$6.3 - $11.35 $427,253 - $769,734
-67,818 Reduced 1.01%
6,616,423 $42.2 Million
Q2 2023

Aug 14, 2023
SELL
$10.62 - $17.34 $1.91 Million - $3.12 Million
-180,144 Reduced 2.62%
6,684,241 $74.1 Million
Q1 2023

May 15, 2023
BUY
$15.35 - $25.65 $2.41 Million - $4.03 Million
157,098 Added 2.34%
6,864,385 $105 Million
Q4 2022

Feb 14, 2023
BUY
$10.06 - $22.66 $15.5 Million - $34.9 Million
1,538,264 Added 29.76%
6,707,287 $149 Million
Q3 2022

Nov 14, 2022
SELL
$15.46 - $23.43 $42 Million - $63.6 Million
-2,714,102 Reduced 34.43%
5,169,023 $84.4 Million
Q2 2022

Aug 15, 2022
SELL
$11.18 - $20.5 $1.14 Million - $2.1 Million
-102,410 Reduced 1.28%
7,883,125 $115 Million
Q1 2022

May 16, 2022
BUY
$14.2 - $23.78 $3.6 Million - $6.03 Million
253,689 Added 3.28%
7,985,535 $147 Million
Q4 2021

Feb 14, 2022
BUY
$20.4 - $28.66 $13.1 Million - $18.4 Million
641,196 Added 9.04%
7,731,846 $184 Million
Q3 2021

Nov 15, 2021
BUY
$18.16 - $25.21 $82.7 Million - $115 Million
4,553,579 Added 179.48%
7,090,650 $175 Million
Q2 2021

Aug 16, 2021
BUY
$19.62 - $29.26 $15.3 Million - $22.8 Million
779,336 Added 44.34%
2,537,071 $62.7 Million
Q1 2021

May 17, 2021
BUY
$20.28 - $28.15 $16.5 Million - $22.9 Million
812,897 Added 86.04%
1,757,735 $38.3 Million
Q4 2020

Feb 16, 2021
BUY
$24.73 - $35.12 $23.4 Million - $33.2 Million
944,838 New
944,838 $24.1 Million

Others Institutions Holding RNA

# of Institutions
256
Shares Held
108M
Call Options Held
517K
Put Options Held
717K
View Full List

About Avidity Biosciences, Inc.

RNA Quotes by TradingView
  • Ticker RNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 52,127,000
  • Market Cap $1.67B
  • Description
  • Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...
More about RNA
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email